Identification, Biopsy, and Treatment of Poorly Understood Premalignant, in Situ, and Indolent Low-Grade Cancers: Are We Becoming Victims of Our Own S

Identification, Biopsy, and Treatment of Poorly Understood Premalignant, in Situ, and Indolent Low-Grade Cancers: Are We Becoming Victims of Our Own Success?
Ferris M. Hall
Radiology 2010;254 655-659
Link to Journal

Imagers are increasingly detecting and performing percutaneous biopsies on borderline, preinvasive, or low-grade cancers that were heretofore rarely identified and that may never progress to meaningful disease.

Large-Core Breast Biopsy: Abnormal Salivary Cortisol Profiles Associated with Uncertainty of Diagnosis

Large-Core Breast Biopsy: Abnormal Salivary Cortisol Profiles Associated with Uncertainty of Diagnosis
Elvira V. Lang, Kevin S. Berbaum, and Susan K. Lutgendorf
Radiology 2009;250 631-637

Link to Journal

Uncertainty about the final diagnosis after LCBB is associated with substantial biochemical distress, which may have adverse effects on immune defense and wound healing. Results indicate the need for more rapid communication of biopsy results
Not only how but also when biopsy results become available to the patient is important to avoid the dysregulation of cortisol secretion, even if the results are benign